Search Results - "YEŞİLKAYA, Selma"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Rapid drug desensitization to taxanes: a descriptive study from Turkey by Yeşilkaya, Selma, Aksu, Kurtuluş, Vural Solak, Gürgün Tuğçe, Demir, Şenay, Topel, Musa, Erçelebi, Dilek Çuhadar, Koca Kalkan, İlkay, Ateş, Hale, Köycü Buhari, Gözde, Nazik Bahçecioğlu, Sakine

    Published in Journal of oncology pharmacy practice (01-12-2024)
    “…To present the characteristics of drug hypersensitivity reactions (DHRs) among taxane recipients with non-small cell lung carcinoma (NSCLC), and to describe…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic by Koca Kalkan, Ilkay, Ates, Hale, Aksu, Kurtulus, Yesilkaya, Selma, Topel, Musa, Cuhadar Ercelebi, Dilek, Turkyilmaz, Suleyman, Oncul, Ali, Demir, Senay

    Published in The World Allergy Organization journal (01-07-2021)
    “…Allergen immunotherapy (AIT) must be continued for 3 years, to achieve a long-term modifying effect. Adherence is a key to ensure effectiveness. The objective…”
    Get full text
    Journal Article
  6. 6

    Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions by Buhari, Gözde Köycü, Kalkan, İlkay Koca, Ateş, Hale, Bahçecioğlu, Sakine Nazik, Demir, Şenay, Yeşilkaya, Selma, Solak, Gürgün Tuğçe Vural, Aksu, Kurtuluş, Erkekol, Ferda Öner

    Published in Allergologia et immunopathologia (01-01-2023)
    “…Although platin desensitization is a safe and effective alternative for patients with hypersensitivity reactions (HSRs), sometimes breakthrough reactions…”
    Get more information
    Journal Article
  7. 7

    Changes in Treatment Adherence During the COVID-19 Pandemic in Patients with Severe Asthma Receiving Biologic Agent Treatment by ATEŞ, Hale, KOCA KALKAN, İlkay, AKSU, Kurtuluş, TOPEL, Musa, YEŞİLKAYA, Selma, DEMİR, Şenay, NAZİK BAHÇECİOĞLU, Sakine

    Published in Çağdaş tıp dergisi (30-09-2022)
    “…Aim: This study aimed to evaluate the effects of the COVID-19 pandemic on treatment adherence in patients with severe asthma who were receiving omalizumab and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The prevalence of chronic bronchitis in adults living in the center of Gumushane by Tutar, Nuri, Yeşilkaya, Selma, Memetoğlu, Mehmet Erdem, Özel, Deniz, Boşnak, Emre

    Published in Tüberküloz ve toraks (01-01-2013)
    “…Chronic bronchitis and emphysema are major components of chronic obstructive pulmonary diseases (COPD). The aim of this study was to determine the prevalence…”
    Get full text
    Journal Article
  10. 10

    COVID-19 in a patient with severe asthma using mepolizumab by Aksu, Kurtuluş, Yesilkaya, Selma, Topel, Musa, Turkyilmaz, Suleyman, Ercelebi, Dilek Cuhadar, Oncul, Ali, Kalkan, Ilkay Koca, Ates, Hale

    Published in Allergy and asthma proceedings (21-03-2021)
    “…There is a lack of information about the course of coronavirus disease 2019 (COVID-19) in patients with severe asthma who were treated with biologics. Some…”
    Get more information
    Journal Article
  11. 11

    Variables predicting clinical remission among adults with severe asthma treated with biologic agents by Yeşilkaya, S, Aksu, K, Tuğçe Vural Solak, G, Akkale, O, Telli, O, Tuğlu, H C, Köycü Buhari, G, Bahçecioğlu, S N, Demir, S

    “…Although biologic agents promise a short- to medium-term remission in asthma, it is unclear whether they can fundamentally alter disease course and achieve…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pulmoner Tromboemboli Olgularında Anjiotensin Konverting Enzim Gen Polimorfizmi by Yeşilkaya, Selma

    Published 01-01-2009
    “…Pulmoner emboli (PE); tanı koyma yöntemlerindeki ilerlemelere karşınhalen tanı ve tedavideki gecikmelerden ötürü morbititesi ve mortalitesi yüksek olan bir…”
    Get full text
    Dissertation